Prevalence Of Testosterone Deficiency In Patients With Chronic Obstructive Pulmonary Disease In King Chulalongkorn Memorial Hospital

Ratchadapisek Sompoch Endowment Fund, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 130 人开始时间: 2019年3月1日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.The 40-year or older male who was diagnosed of COPD by internist or pulmonologist.
•2.The patients who give the informed consent and agree to follow to the study protocol.

•1.Underlying disease or history of these illnesses such as,
•1.1End stage renal disease which defined as creatinine clearance less than 15 ml/min/1.73 m2
•1.2Cirrhosis
•1.3History of active malignancy or recent chemotherapeutic medication within 5 years
•1.4Chronic anemia such as thalassemia who needed regular blood transfusion or finding of hemochromatosis
•1.5Active rheumatoid arthritis
•1.6Poor control of type 2 diabetes who have HbA1c > 8 %
•1.7Severe morbid obesity which defined as â‰¥ 30 kg/m2
•1.8Acute myocardial infarction or chest pain or dyspnea within 1 year
•2.Diagnosed of hypogonadism before the inclusion period
•3.Stop testosterone supplement and advice the patients to use as needed
•4.Withdraw from the target
•5.After acute exacerbation or admission who got systemic corticosteroid within 4 months
•6.Available for listening, reading, or speaking in English
•7.Contraindications of 6-minute walk test are
•7.1Acute myocardial infarction or chest pain (active) off prednisolone already
•7.2Systolic blood pressure > 180 mmHg or diastolic blood pressure > 120 mmHg and duration of pulse rate > 120 beat/min

发起方

Ratchadapisek Sompoch Endowment Fund, Faculty of Medicine, Chulalongkorn University